New application of NU6300

The invention provides novel application of NU6300, and belongs to the technical field of medicine. The invention provides a new application of NU6300 in inhibition of pyroptosis. The invention verifies that the NU6300 has a treatment effect on colitis by inhibiting pyroptosis and remarkably reducin...

Full description

Saved in:
Bibliographic Details
Main Authors WU WENSHUANG, YE HAOYU, JIANG XUEQIN
Format Patent
LanguageChinese
English
Published 03.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides novel application of NU6300, and belongs to the technical field of medicine. The invention provides a new application of NU6300 in inhibition of pyroptosis. The invention verifies that the NU6300 has a treatment effect on colitis by inhibiting pyroptosis and remarkably reducing DSS-induced epithelium and mucous membrane lesions, crypt dilation and goblet cell depletion, and verifies that the NU6300 has a protection effect on LPS-induced sepsis by inhibiting pyroptosis, and the protection effect of the NU6300 on the LPS-induced sepsis is superior to that of NAS. It is proved that NU6300 can play an important role in drugs for treating pyroptosis-mediated diseases and has good clinical application value. 本发明提供了一种NU6300的新用途,属于医学技术领域。本发明提供了NU6300抑制细胞焦亡的新用途。并且本发明验证了NU6300通过抑制细胞焦亡,显著减轻DSS诱导的上皮和黏膜损伤、隐窝扩张和杯状细胞耗竭对结肠炎有治疗作用,以及验证了NU6300通过抑制细胞焦亡,对LPS诱导的脓毒症的保护作用,且NU6300对LPS诱导的脓毒症的保护作用优于NAS。证实NU6300可以在细胞焦亡介导的疾病治疗药物中起到重要作用,具有很好的临床应用价值。
AbstractList The invention provides novel application of NU6300, and belongs to the technical field of medicine. The invention provides a new application of NU6300 in inhibition of pyroptosis. The invention verifies that the NU6300 has a treatment effect on colitis by inhibiting pyroptosis and remarkably reducing DSS-induced epithelium and mucous membrane lesions, crypt dilation and goblet cell depletion, and verifies that the NU6300 has a protection effect on LPS-induced sepsis by inhibiting pyroptosis, and the protection effect of the NU6300 on the LPS-induced sepsis is superior to that of NAS. It is proved that NU6300 can play an important role in drugs for treating pyroptosis-mediated diseases and has good clinical application value. 本发明提供了一种NU6300的新用途,属于医学技术领域。本发明提供了NU6300抑制细胞焦亡的新用途。并且本发明验证了NU6300通过抑制细胞焦亡,显著减轻DSS诱导的上皮和黏膜损伤、隐窝扩张和杯状细胞耗竭对结肠炎有治疗作用,以及验证了NU6300通过抑制细胞焦亡,对LPS诱导的脓毒症的保护作用,且NU6300对LPS诱导的脓毒症的保护作用优于NAS。证实NU6300可以在细胞焦亡介导的疾病治疗药物中起到重要作用,具有很好的临床应用价值。
Author JIANG XUEQIN
YE HAOYU
WU WENSHUANG
Author_xml – fullname: WU WENSHUANG
– fullname: YE HAOYU
– fullname: JIANG XUEQIN
BookMark eNrjYmDJy89L5WSQ9EstV0gsKMjJTE4syczPU8hPU_ALNTM2MOBhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoaGZpYWxsaGxo7GxKgBAHlpIyM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate NU6300的新用途
ExternalDocumentID CN116983313A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN116983313A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:03:50 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN116983313A3
Notes Application Number: CN202310859640
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231103&DB=EPODOC&CC=CN&NR=116983313A
ParticipantIDs epo_espacenet_CN116983313A
PublicationCentury 2000
PublicationDate 20231103
PublicationDateYYYYMMDD 2023-11-03
PublicationDate_xml – month: 11
  year: 2023
  text: 20231103
  day: 03
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies SICHUAN UNIVERSITY
RelatedCompanies_xml – name: SICHUAN UNIVERSITY
Score 3.6371598
Snippet The invention provides novel application of NU6300, and belongs to the technical field of medicine. The invention provides a new application of NU6300 in...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title New application of NU6300
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231103&DB=EPODOC&locale=&CC=CN&NR=116983313A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAfbPUizMLQyAWdwwVdfEzMhQN9E4xVQ3yQzY2DBPNjc0TAXtRvb1M_MINfGKMI1gYsiC7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuatDeMbCxYmhgrObiZOsa4O_i76zm7Gzr7KfmF2RraGhmaWFsbGjsyMzACmpGg87Zdw1zAu1KKUCuUtwEGdgCgKbllQgxMFVlCDNwOsNuXhNm4PCFTngDmdC8VyzCIAksjxSQ5psV8tMU_EJBZ1mJMii6uYY4e-gC7YiHeyje2Q_hHGMxBhZgRz9VgkEB2JdISjI0TU00TgK2CiyTEw3SkpMSjY0SLY0Mk4ANL0kGKdzmSOGTlGbgAgUOeA-dsQwDS0lRaaossDItSZIDhwIAQe915w
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAfbPUizMLQyAWdwwVdfEzMhQN9E4xVQ3yQzY2DBPNjc0TAXtRvb1M_MINfGKMI1gYsiC7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuatDeMbCxYmhgrObiZOsa4O_i76zm7Gzr7KfmF2RraGhmaWFsbGjsyMzAag46nRfUdApzAu1KKUCuUtwEGdgCgKbllQgxMFVlCDNwOsNuXhNm4PCFTngDmdC8VyzCIAksjxSQ5psV8tMU_EJBZ1mJMii6uYY4e-gC7YiHeyje2Q_hHGMxBhZgRz9VgkEB2JdISjI0TU00TgK2CiyTEw3SkpMSjY0SLY0Mk4ANL0kGKdzmSOGTlGfg9Ajx9Yn38fTzlmbgAgUUeD-dsQwDS0lRaaossGItSZIDhwgA7WV41A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=New+application+of+NU6300&rft.inventor=WU+WENSHUANG&rft.inventor=YE+HAOYU&rft.inventor=JIANG+XUEQIN&rft.date=2023-11-03&rft.externalDBID=A&rft.externalDocID=CN116983313A